Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Breast Neoplasms
×
efineptakin alfa
×
Clear all
Filters
3
NCT03752723
2024-03-05
KEYNOTE-899
Genexine, Inc.
Phase 1/2
Completed
84 enrolled